Results 21 to 30 of about 94,881 (302)

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

open access: yesInternational Journal of Neonatal Screening, 2019
Since 2001, the Brazilian Ministry of Health has been coordinating a National Neonatal Screening Program (NNSP) that now covers all the 26 states and the Federal District of the Brazilian Republic and targets six diseases including sickle cell disease ...
Ana C. Silva-Pinto   +4 more
doaj   +1 more source

Osteoporosis in thalassaemia

open access: yesThalassemia Reports, 2018
Osteoporosis is a prominent cause of morbidity in patients with thalassaemia major (TM) with a complex pathophysiology. Patients with TM and osteoporosis have elevated markers of bone resorption.
Ersi Voskaridou   +2 more
doaj   +1 more source

The patient as a partner in promoting healthcare policies and research

open access: yesThalassemia Reports, 2014
Not ...
Marco Bianchi   +1 more
doaj   +1 more source

RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice

open access: yesHaematologica, 2018
Sickle cell disease patients are at increased risk of developing a chronic kidney disease. Endothelial dysfunction and inflammation associated with hemolysis lead to vasculopathy and contribute to the development of renal disease.
Alfia Khaibullina   +8 more
doaj   +1 more source

Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey

open access: yesFrontiers in Genetics, 2022
Background: Sickle cell disease, the inherited blood disorder characterized by anemia, severe pain and other vaso-occlusive complications, acute chest syndrome, disproportionate hospitalization, and early mortality, has significant financial, social, and
Emmanuel Chide Okocha   +13 more
doaj   +1 more source

Calibrating Sickle Cell Disease [PDF]

open access: yesBiophysical Journal, 2016
Sickle cell disease is fundamentally a kinetic disorder, in which cells containing the mutated hemoglobin (hemoglobin S; HbS) will cause occlusion if they sickle in the microvasculature, but have minimal (or no) consequences if they sickle in the venous return.
Donna Yosmanovich   +3 more
openaire   +2 more sources

Transition Readiness of Pediatric Sickle Cell Patients to Adult Clinic in a Teaching Hospital, Ghana

open access: yesAdvances in Hematology
Conclusion: The study revealed a high transition readiness among pediatric patients. In general, the patients had high confidence transitioning to an adult clinic and the ability to manage their own healthcare.
Aaron Kwasi Nartey   +7 more
doaj   +1 more source

Personalizing the Pediatric Hematology/Oncology Fellowship: Adapting Training for the Next Generation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT The pediatric hematology‐oncology fellowship training curriculum has not substantially changed since its inception. The first year of training is clinically focused, and the second and third years are devoted to scholarship. However, this current structure leaves many fellows less competitive in the current job market, resulting in ...
Scott C. Borinstein   +3 more
wiley   +1 more source

Antiviral response and HIV-1 inhibition in sickle cell disease

open access: yesiScience
Summary: Sickle cell disease (SCD) is characterized by hemolysis, vaso-occlusion, and ischemia. HIV-1 infection was previously shown to be suppressed in SCD PBMCs.
Namita Kumari   +10 more
doaj   +1 more source

HSP70 governs permeability and mechanotransduction in primary human endothelial cells

open access: yesFEBS Open Bio, EarlyView.
HSP70 chemical inhibition reduces endothelial cell proliferation and increases permeability, the latter supported by normal interendothelial junctional protein distribution. HSP70 also plays a role in shear stress response, a hemodynamic force naturally present in blood vessels and correlated with vessel protection.
Andrea Pinto‐Martinez   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy